RxDoctor Payments Data

Nicholas Manguso, MD

Surgery · Reno, NVNPI 1093199457

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. Histosonics, Inc. accounts for 86.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $6,357, 6.4 times the $1,000 reported in 2019.

$9,780in general payments, 2019–2025

Across 12 payments — averaging $815.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$8K
  • Intuitive Surgical$1K
  • Springworks Therapeutics, Inc.$109
  • Medtronic$105
  • TELA Bio, Inc.$48
  • Sobi, Inc$31
  • plus $17 from 1 others
$85,807in research payments, 2019–2025

Across 1 payment — averaging $85,807 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Histosonics, Inc.$86K

What the payments were for

  • Consulting fees$5,60057%
  • Travel & lodging$2,57626%
  • Food & beverage$6056%
  • Education$1,00010%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,780 in reported general payments places this provider in the 70th percentile of 209 surgery providers in Nevada.

See all surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$92,870
Medicare patients
138
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl19$40

Paid to pharmacies, not to this prescriber.

Other surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →